China’s Dependency Levers Are Now Part of Deal Feasibility

Beijing’s controls and access restrictions are now shaping whether cross-border deals can clear, close, and operate.

Updated

What is this trend?

China’s export controls, blacklists, and access restrictions are turning geopolitical dependency into a direct test of whether M&A deals can actually close.

  • China-linked components, data, and approvals can now stop a deal after signing.
  • Diligence must map supply chains, counterparties, and certification paths earlier.
  • Approval-path modeling is becoming as important as valuation and structure.
  • Deals in biotech, drones, robotics, and industrial tech face the sharpest exposure.

What’s the latest?

Beijing’s moves this week made feasibility a live closing risk: China blacklisted six U.S.

AI control layers, China deal risk, and sponsor exit readiness reshape corp dev

How it developed

  1. Regulatory screening front-loads deals, sponsor exits face disclosure scrutiny, and AI diligence goes software-first

  2. Power-Ready Capacity, CFIUS Enforcement, and India’s Secondary Sale Surge

Go deeper

Curated long-form picks on this trend — podcasts, videos, and analysis, by seniority.

Stay ahead in Corporate Development (M&A)

Get the weekly Corporate Development (M&A) brief in your inbox — the developments, what they mean by seniority, and what to do next.